Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Feb 21, 2008; 14(7): 1126-1132
Published online Feb 21, 2008. doi: 10.3748/wjg.14.1126
Published online Feb 21, 2008. doi: 10.3748/wjg.14.1126
Table 2 Effect of KAI1 expression on in vivo tumor growth (mean ± SD)
| Group | n | Tumor volume (cm3) | t | P | |
| Control | 6 | 4.61 ± 1.98 | - | - | |
| A | KAI1-LipofectAMINE | 6 | 1.22 ± 0.31 | 2.860 | < 0.05 |
| pCMV-KAI1 | 6 | 1.67 ± 0.81 | 2.414 | < 0.05 | |
| Control | 6 | 4.61 ± 1.98 | - | - | |
| B | KAI1-LipofectAMINE | 6 | 4.87 ± 1.58 | 0.199 | > 0.05 |
| pCMV-KAI1 | 6 | 4.16 ± 2.81 | 0.286 | > 0.05 |
- Citation: Xu JH, Guo XZ, Ren LN, Shao LC, Liu MP. KAI1 is a potential target for anti-metastasis in pancreatic cancer cells. World J Gastroenterol 2008; 14(7): 1126-1132
- URL: https://www.wjgnet.com/1007-9327/full/v14/i7/1126.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.1126